Reported Standalone quarterly numbers for Natco Pharma are:Net Sales at Rs 464.70 crore in June 2019 down 9.89% from Rs. 515.70 crore in June 2018.
Quarterly Net Profit at Rs. 147.70 crore in June 2019 down 21.69% from Rs. 188.60 crore in June 2018.
EBITDA stands at Rs. 216.10 crore in June 2019 down 17.14% from Rs. 260.80 crore in June 2018.
Natco Pharma EPS has decreased to Rs. 8.11 in June 2019 from Rs. 10.22 in June 2018.
Natco Pharma shares closed at 552.95 on August 08, 2019 (NSE) and has given -18.92% returns over the last 6 months and -31.99% over the last 12 months.
| Natco Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'19 | Mar'19 | Jun'18 | | Net Sales/Income from operations | 464.70 | 416.30 | 515.70 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 464.70 | 416.30 | 515.70 | | EXPENDITURE | | Consumption of Raw Materials | 66.80 | 79.10 | 88.80 | | Purchase of Traded Goods | 0.40 | 0.90 | 0.30 | | Increase/Decrease in Stocks | 4.20 | -19.20 | -9.00 | | Power & Fuel | -- | -- | -- | | Employees Cost | 88.00 | 76.90 | 85.20 | | Depreciation | 21.60 | 21.30 | 18.30 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 109.60 | 128.40 | 125.30 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 174.10 | 128.90 | 206.80 | | Other Income | 20.40 | 30.70 | 35.70 | | P/L Before Int., Excpt. Items & Tax | 194.50 | 159.60 | 242.50 | | Interest | 6.20 | 5.20 | 2.70 | | P/L Before Exceptional Items & Tax | 188.30 | 154.40 | 239.80 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 188.30 | 154.40 | 239.80 | | Tax | 40.60 | 31.00 | 51.20 | | P/L After Tax from Ordinary Activities | 147.70 | 123.40 | 188.60 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 147.70 | 123.40 | 188.60 | | Equity Share Capital | 36.40 | 36.50 | 36.90 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 8.11 | 6.73 | 10.22 | | Diluted EPS | 8.09 | 6.72 | 10.19 | | EPS After Extra Ordinary | | Basic EPS | 8.11 | 6.73 | 10.22 | | Diluted EPS | 8.09 | 6.72 | 10.19 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months at 289. Use code FREEDOM. 
